Arestin and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Arestin (minocycline hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xeljanz Xr, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Arestin. It is created by eHealthMe based on reports of 788 people who have side effects when taking Arestin from the FDA, and is updated regularly.

What is Arestin?

Arestin has active ingredients of minocycline hydrochloride. eHealthMe is studying from 807 Arestin users. Check the latest studies of Arestin.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,274 drugs and 1,653 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

On Jul, 10, 2026

788 people reported to have side effects when taking Arestin.
Among them, 21 people (2.66%) have Dyspnea exacerbated.

Could Arestin cause Dyspnea exacerbated?

Among these 21 people:

How long have people been on Arestin when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Arestin? *

female: 58.82 %
male: 41.18 %

What is the age of people who have Dyspnea exacerbated when taking Arestin? *

What are other drugs people take besides Arestin? *

Xeljanz Xr: 4 people, 19.05%
Folic Acid: 2 people, 9.52%
Zyrtec: 1 person, 4.76%
Coumadin: 1 person, 4.76%
Gabapentin: 1 person, 4.76%
Fluoxetine Hydrochloride: 1 person, 4.76%
Fish Oil: 1 person, 4.76%
Femara: 1 person, 4.76%
Fareston: 1 person, 4.76%
Diazepam: 1 person, 4.76%

What are other side effects people have besides Dyspnea exacerbated? *

Swollen Tongue (swelling of tongue): 3 people, 14.29%
Swallowing Difficulty: 3 people, 14.29%
Cataract (clouding of the lens inside the eye): 2 people, 9.52%
Hypersensitivity: 2 people, 9.52%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Fatigue (feeling of tiredness): 2 people, 9.52%
Drug Hypersensitivity: 2 people, 9.52%
Pain: 2 people, 9.52%
Blindness: 2 people, 9.52%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 19.05%
Periodontal Disease (disease that attacks the gum and bone and around the teeth): 3 people, 14.29%
Tooth Disorder (tooth disease): 2 people, 9.52%
Multiple Myeloma (cancer of the plasma cells): 1 person, 4.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.76%
Diabetes: 1 person, 4.76%
Anaesthesia: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Arestin and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Arestin:

Arestin (807 reports)

Browse all side effects of Arestin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,274 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,653 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on minocycline hydrochloride (the active ingredients of Arestin) and Arestin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.